DJIA 18,034.93 208.63 1.17%
NASDAQ 4,994.60 62.79 1.27%
S&P 500 2,100.40 19.22 0.92%
market minute promo

CLOVIS ONCOLOGY INC (NASDAQ: CLVS)



company name or ticker

CLVS January 2016 Options Begin Trading

Sector Update: Health-Care Stocks Mixed Pre-Market

Competition And Momentum Weighing On Clovis Oncology

Top Swing Trade Ideas for Monday, August 11: Coach, Clovis Oncology, More

Clovis Oncology's (CLVS) CEO Patrick Mahaffy on Q2 2014 Results - Earnings Call Transcript

Biotech Enters Reporting Season With Large Caps Central To Sector Performance

Better Buy: Clovis Oncology vs. Sunesis Pharmaceuticals

Clovis Oncology and Sunesis Pharmaceuticals are facing pivotal catalysts for their experimental cancer drugs. Which company offers the better risk-to-reward ratio?

3 Stocks Tumbling This Month: Clovis Oncology, Hyperion Therapeutics, and Puma Biotechnology

Puma Biotechnology (PBYI), Clovis Oncology (CLVS), and Hyperion Therapeutics (HPTX) all stumbled by more than 10% in June.

Interesting CLVS Put And Call Options For August 16th

Clovis Oncology Initiates Study on CO-1686 - Analyst Blog

See More Articles...